Cytodyn Inc (CYDY)

[B52T38]

So I put myself in Nader's shoes and, besides the tightness of the fit, I see a huge reason why I wouldn't PR hitting the primary endpoint.

In short, "The FDA asked me to hold off."

Did they really say that? Who knows. But that COULD be a reason they did not PR hitting their primary endpoint. And if you were N.P. and had a drug that had dozens of possible applications - and you were still looking for approval of your first - wouldn't you want to stay in their good grace? Would it make sense to embarrass the FDA, destroy your working relationship with the entity that holds your financial future?

I'm pretty ignorant about medical/FDA stuff, but I assume there's lots of moving parts to this, especially with other nations involved. So if the FDA requests a blackout period so they can line up their ducks, why not?

The entire future of CYDY depends on FDA approval, so let's work with them, not against.